Long-Term Intravitreal Ranibizumab as a Potential Additional Risk Factor for Neurodegeneration in Parkinson's Disease: A Case Report

• Main Authors: Gianluca Trifirò (Author), Ilaria Marcianò (Author), Paola M. Cutroneo (Author), Edoardo Spina (Author), Eliana Mirabelli (Author), Costantino J. Trombetta (Author), Francesca Morgante (Author)
• Format: Book
• Published: Frontiers Media S.A., 2018-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

In November 2012, a 72-year old patient was diagnosed with left eye wet age-related macular degeneration. The patient received three monthly intravitreal injections of ranibizumab, with complete resolution of retinal hemorrhage and edema and reinstatement of visual acuity. In May 2015, symptomatic r...